Imagenebio (IMA): Director reported a transaction in 337K units

337K

Derivative units

Traded

Apr 14, 2026

Filed

Apr 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 12, 2026, Steven Hui Wang resigned as a member of the Board of Directors (the “Board”) of ImageneBio, Inc. (the “Company”), effective immediately. Mr. Wang’s resignation was not the result of any disagreement with the Company on any matter related to the Company’s operations, policies, practices or strategy.”
2. Mar 10, 2026Company filing · Form 8-K · ResultsReported its results
3. Mar 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 12, 2026, ImageneBio, Inc. (the “Company”) and Erin Butler, the Company’s Senior Vice President, Finance & Administration and Principal Accounting Officer, agreed to a mutual separation effective March 20, 2026 (the “Butler Separation Date”).”
4. Apr 12, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them

What came next

1. May 7, 2026Company filing · Form 8-K · ResultsReported its results
2. Jun 16, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 16, 2026, ImageneBio, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”
3. Jun 22, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 22, 2026, Robert Lally, our Senior Vice President of Finance and Operations and principal accounting officer, provided notice of his resignation, effective July 22, 2026.”
4. Jul 16, 2026InsiderOfficer sold ~$9.2K of IMA shares in the open market
5. Jul 17, 2026InsiderOfficer sold ~$8.1K of IMA shares in the open market
6. Jul 20, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On July 20, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), based in part on the recommendation of Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, appointed Yanina Grant-Huerta as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective July 20, 2026.”
7. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Imagenebio

OQRO holds no insider, Congress, fund or contract record for Imagenebio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMA page.

Other recent filings by David P Bonita, Director

• SEC Form 4 at Imagenebio (IMA)Jul 30, 2025

The full history of David P Bonita, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Imagenebio

• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Jul 21, 2026
• SEC Form 4Jul 21, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 4Dec 29, 2025
• SEC Form 4Jul 30, 2025

Everything OQRO holds on this company is on its IMA page.